This case examines the microeconomic pricing related to the sale of inexpensive vaccines for use in developing countries. Thing to describe the historical success of the United Nations so-called "tiered pricing" policy. This policy has allowed the World Health Organization to purchase large volumes of vaccine on the marginal production cost of vaccines, often only a few cents per dose, while the developed countries paid full average cost, often many times more. Changing political situation and the cost structure of new vaccines threatens decades of agreement, however. HKS Case Number 1450.0 "Hide
by Susan Rosegrant, Jose Gomez-Ibanez 16 pages. Publication date: 01 Nov 1997. Prod. #: HKS499-PDF-ENG
Related Case Solutions & Analyses:
Flexible Footprints: Reconfiguring MNCs for New Value Opportunities
Ambrose & Bisaro
The Guggenheims and Chilean Nitrates
Infineon Raceway (Sears Point Raceway): Marketing in the Motorsports World
CEIBS: Global Business School Made in China
PROTECT- Promoting Civil Society in Serbia
Wal-Mart Puerto Rico: Promoting Development Through a Public-Private Partnership
Competing in the Global Marketplace: The Case of India and China
Bombardier (A): The Procurement Decision of Light Rail Cars for the Los Angeles Metro Transit Authority
Launching a Business Accelerator: venVelo
